Evidence map›Paper›PMID 34363521›Full record

ArticleBrain structure & function2021

Structural connectivity and subcellular changes after antidepressant doses of ketamine and Ro 25-6981 in the rat: an MRI and immuno-labeling study.

Raquel Pascual-Antón, Arantxa Blasco-Serra, Emma Muñoz-Moreno, Fuencisla Pilar-Cuéllar, Emilio Garro-Martínez, Eva Florensa-Zanuy, Xavier López-Gil, Víctor M Campa, Guadalupe Soria, Albert Adell

Open access · hybridAbstract read
In one paragraph

Article in Brain structure & function, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Raquel Pascual-AntónInstitute of Biomedicine and Biotechnology of Cantabria, IBBTEC (CSIC, University of Cantabria), Calle Albert Einstein 22 (PCTCAN), Santander, Spain.
Arantxa Blasco-SerraGESADA Laboratory, Department of Human Anatomy and Embryology, University of Valencia, Valencia, Spain.
Emma Muñoz-MorenoExperimental MRI 7T Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Fuencisla Pilar-CuéllarInstitute of Biomedicine and Biotechnology of Cantabria, IBBTEC (CSIC, University of Cantabria), Calle Albert Einstein 22 (PCTCAN), Santander, Spain.
Emilio Garro-MartínezInstitute of Biomedicine and Biotechnology of Cantabria, IBBTEC (CSIC, University of Cantabria), Calle Albert Einstein 22 (PCTCAN), Santander, Spain.
Eva Florensa-ZanuyInstitute of Biomedicine and Biotechnology of Cantabria, IBBTEC (CSIC, University of Cantabria), Calle Albert Einstein 22 (PCTCAN), Santander, Spain.
Xavier López-GilExperimental MRI 7T Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Víctor M CampaInstitute of Biomedicine and Biotechnology of Cantabria, IBBTEC (CSIC, University of Cantabria), Calle Albert Einstein 22 (PCTCAN), Santander, Spain.
Guadalupe SoriaExperimental MRI 7T Unit, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Albert AdellInstitute of Biomedicine and Biotechnology of Cantabria, IBBTEC (CSIC, University of Cantabria), Calle Albert Einstein 22 (PCTCAN), Santander, Spain. albert.adell@unican.es.ORCID http://orcid.org/0000-0003-0570-4931
Universidad de Cantabria · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESCentro de Investigación Biomédica en Red de Salud Mental · ESUniversitat de València · ES

Funding

Conselleria d'Educació, Investigació, Cultura i Esport GV/2018/049Instituto de Salud Carlos III PI13/00038Instituto de Salud Carlos III PI16/00217Instituto de Salud Carlos III PI19/00170Ministerio de Ciencia, Innovación y Universidades RTI2018-097534-B-I00
6 · The paper itself

Abstract

Ketamine has rapid and robust antidepressant effects. However, unwanted psychotomimetic effects limit its widespread use. Hence, several studies examined whether GluN2B-subunit selective NMDA antagonists would exhibit a better therapeutic profile. Although preclinical work has revealed some of the mechanisms of action of ketamine at cellular and molecular levels, the impact on brain circuitry is poorly understood. Several neuroimaging studies have examined the functional changes in the brain induced by acute administration of ketamine and Ro 25-6981 (a GluN2B-subunit selective antagonist), but the changes in the microstructure of gray and white matter have received less attention. Here, the effects of ketamine and Ro 25-6981 on gray and white matter integrity in male Sprague-Dawley rats were determined using diffusion-weighted magnetic resonance imaging (DWI). In addition, DWI-based structural brain networks were estimated and connectivity metrics were computed at the regional level. Immunohistochemical analyses were also performed to determine whether changes in myelin basic protein (MBP) and neurofilament heavy-chain protein (NF200) may underlie connectivity changes. In general, ketamine and Ro 25-6981 showed some opposite structural alterations, but both compounds coincided only in increasing the fractional anisotropy in infralimbic prefrontal cortex and dorsal raphe nucleus. These changes were associated with increments of NF200 in deep layers of the infralimbic cortex (together with increased MBP) and the dorsal raphe nucleus. Our results suggest that the synthesis of NF200 and MBP may contribute to the formation of new dendritic spines and myelination, respectively. We also suggest that the increase of fractional anisotropy of the infralimbic and dorsal raphe nucleus areas could represent a biomarker of a rapid antidepressant response.

Indexed as

Antidepressive AgentsKetaminePhenolsPiperidinesAnimalsDorsal Raphe NucleusMagnetic Resonance ImagingMalePrefrontal CortexRatsRats, Sprague-DawleyAntidepressive AgentsKetaminePhenolsPiperidinesRo 25-6981Dorsal raphe nucleusFast-acting antidepressantInfralimbic cortexMyelinizationNeurofilamentNeuroimaging

Identifiers

PMID34363521
PMCPMC8448713
OpenAlexW3192594239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.